Sucampo Pharmaceuticals, Inc. Duration-Based Stock Option Incentive Award Stock Option Agreement Terms and ConditionsStock Option Agreement • March 11th, 2016 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 11th, 2016 Company Industry JurisdictionThis Incentive Stock Option Agreement, along with the Sucampo Pharmaceuticals, Inc. Duration -Based Stock Option Incentive Award Summary delivered herewith (the "Award Summary"), once signed by the individual named on the Award Summary (the "Participant"), shall constitute an Agreement made as of the Grant Date (as indicated on the Award Summary), by and between Sucampo Pharmaceuticals, Inc., a Delaware corporation having its principal office at 805 King Farm Boulevard, Suite 550, Rockville, MD 20850 (“Sucampo” and with its direct and indirect subsidiaries, the "Company"), and the Participant.
Sucampo Pharmaceuticals, Inc. Duration and Performance-Based Stock Option Incentive Award Stock Option Agreement Terms and ConditionsStock Option Agreement • May 6th, 2011 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 6th, 2011 Company Industry JurisdictionThis Incentive Stock Option Agreement, along with the Sucampo Pharmaceuticals, Inc. Duration and Performance-Based Stock Option Incentive Award Summary delivered herewith (the "Award Summary"), once signed by the individual named on the Award Summary (the "Participant"), shall constitute an Agreement made as of the Grant Date (as indicated on the Award Summary), by and between Sucampo Pharmaceuticals, Inc., a Delaware corporation having its principal office at 4520 East-West Highway, Third Floor, Bethesda, MD 20184 (“Sucampo” and with its direct and indirect subsidiaries, the "Company"), and the Participant.